Aquamin® Study Aims to Prevent Pouchitis in Ulcerative Colitis Patients
A clinical trial is investigating the efficacy of Aquamin® in preventing pouchitis in patients with J-pouch after ulcerative colitis surgery.
Asset / Drug
Drug and asset intelligence for Aquamin with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.